查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946645

2026年全球癌症分子诊断市场报告

Oncology Molecular Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，肿瘤分子诊断市场发展迅速，预计将从2025年的56.5亿美元成长到2026年的63.4亿美元，复合年增长率达12.2%。过去几年成长要素包括癌症发生率的上升、PCR和定序技术的广泛应用、肿瘤研究经费的增加、医院诊断服务的扩展以及分子检测的监管核准。

预计未来几年肿瘤分子诊断市场将快速成长，到2030年市场规模将达到101.3亿美元，复合年增长率（CAGR）为12.4%。预测期内的成长要素包括精准肿瘤学的应用、液态生物检体技术的进步、对个人化治疗的需求、人工智慧赋能的数据分析以及新兴市场的渗透。预测期内的主要趋势包括伴随诊断的增长、液态生物检体应用的增加、基于生物标誌物的检测的扩展、癌症筛检项目数量的增加以及对早期精准癌症检测的需求。

对个人化医疗日益增长的需求将进一步推动肿瘤分子诊断市场的未来扩张。个人化医疗专注于根据患者的个别特征（包括基因组成和疾病谱）量身定制的医疗方案和干预措施。分子肿瘤诊断在个人化癌症治疗中发挥重要作用，它能够实现精准的肿瘤分析、优化药物选择和製定个人化的治疗策略，从而改善临床疗效和患者生活品质。例如，根据美国非营利组织「个人化医疗联盟」（Personalized Medicine Alliance）统计，截至2024年2月，美国食品药物管理局（FDA）在2023年核准了16种针对罕见疾病患者的新型个人化疗法，高于2022年的6种。个人化医疗的不断普及正在推动肿瘤分子诊断市场的发展。

肿瘤分子诊断市场的关键参与者正在推动基因组技术的发展，例如新一代基因测序、计算分析和创新肿瘤建模，以改善癌症早期检测、突变识别和个人化治疗策略。这些进步提高了诊断准确性，加快了结果出炉速度，并满足了社区对高精度分子检测日益增长的需求。例如，2024年5月，总部位于加拿大的精准肿瘤学服务供应商OncoHelix-CoLab与阿联酋布尔吉尔控股公司合作，在阿联酋布尔吉尔医疗城开设了一家最先进的实验室。该实验室将能够进行本地化的先进分子和免疫学检测，增强区域诊断能力，并透过伙伴关係（例如ClarityDX前列腺癌检测）支援多种癌症类型的检测，包括前列腺癌。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球癌症分子诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 身临其境型技术（AR/VR/XR）与数位体验
  • 主要趋势
    • 伴随诊断的发展
    • 液态生物检体的应用日益广泛
    • 扩大基于生物标记的检测
    • 增加癌症筛检项目
    • 对早期准确癌症检测的需求

第五章 终端用户产业市场分析

  • 医院
  • 诊断中心
  • 学术机构
  • 研究所
  • 癌症诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球癌症分子诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球癌症分子诊断市场规模、比较及成长率分析
  • 全球癌症分子诊断市场表现：规模与成长，2020-2025年
  • 全球癌症分子诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 设备、试剂及其他产品
  • 透过技术
  • 聚合酵素链锁反应（PCR）、原位杂合反应（ISH）、恒温核酸增幅技术（INNAT）、晶片和微阵列、定序、质谱分析、转录媒介增幅（TMA）以及其他技术
  • 最终用户
  • 医院、诊断中心、学术研究机构和其他最终用户
  • 按类型细分：设备
  • 聚合酵素链锁反应（PCR）仪、定序仪、微阵列平台和萤光原位杂合反应（FISH）仪
  • 按类型细分：试剂
  • DNA与RNA萃取试剂盒、PCR试剂与试剂盒、NGS样品製备试剂盒、诊断检测试剂
  • 按类型细分：其他产品
  • 数据分析与解释软体、品管及校准产品、耗材、肿瘤检测用生物标记

第十章 区域与国家分析

  • 全球癌症分子诊断市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球癌症分子诊断市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 癌症分子诊断市场：竞争格局及市场占有率（2024年）
  • 癌症分子诊断市场：公司估值矩阵
  • 癌症分子诊断市场：公司概况
    • F. Hoffmann-La Roche AG
    • Bayer AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第37章：其他领先和创新企业

  • Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年癌症分子诊断市场：提供新机会的国家
  • 2030年癌症分子诊断市场：蕴藏新机会的细分市场
  • 2030年癌症分子诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME6MOMDO01_G26Q1

Oncology molecular diagnostics involve tests that analyze genes, proteins, and related molecules to diagnose cancers and guide treatment decisions.

The primary products in the oncology molecular diagnostics market include instruments, reagents, and others. Oncology molecular diagnostic instruments are utilized for the detection and diagnosis of cancer. The technologies involved include polymerase chain reaction (PCR), in-situ hybridization (ISH), isothermal nucleic acid amplification technology (INNAT), chips and microarrays, sequencing, mass spectrometry, transcription-mediated amplification (TMA), and others. These products are used by end users such as hospitals, diagnostic centers, academic institutions, research organizations, and others.

Tariffs are impacting the oncology molecular diagnostics market by increasing costs of imported sequencing instruments, reagents, and analytical software components. Reagents and instruments segments are most impacted, especially in North America and Asia-Pacific where advanced diagnostics are widely deployed. Elevated costs may delay technology upgrades for diagnostic centers. Conversely, tariffs are encouraging regional manufacturing, domestic reagent production, and strategic collaborations to reduce dependency on imports.

The oncology molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides oncology molecular diagnostics market statistics, including oncology molecular diagnostics industry global market size, regional shares, competitors with a oncology molecular diagnostics market share, detailed oncology molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the oncology molecular diagnostics industry. This oncology molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncology molecular diagnostics market size has grown rapidly in recent years. It will grow from $5.65 billion in 2025 to $6.34 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing cancer prevalence, adoption of PCR and sequencing, oncology research funding, hospital diagnostic expansion, regulatory approvals for molecular tests.

The oncology molecular diagnostics market size is expected to see rapid growth in the next few years. It will grow to $10.13 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to precision oncology adoption, liquid biopsy advancements, personalized treatment demand, AI-driven data interpretation, emerging market penetration. Major trends in the forecast period include growth in companion diagnostics, rising use of liquid biopsy, expansion of biomarker-based testing, increasing cancer screening programs, demand for early and accurate cancer detection.

The increasing demand for personalized medicine is increasingly supporting the expansion of the oncology molecular diagnostics market going forward. Personalized medicine focuses on tailoring medical treatments and interventions to individual patient characteristics, including genetic makeup and disease profiles. Oncology molecular diagnostics play a critical role in personalized cancer care by enabling precise tumor profiling, optimized drug selection, and individualized treatment strategies that improve clinical outcomes and patient quality of life. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, compared to six approvals in 2022. Consequently, the rising adoption of personalized medicine is strengthening the oncology molecular diagnostics market.

Leading companies operating in the oncology molecular diagnostics market are advancing genomics technologies such as next-generation cancer genome sequencing, computational analytics, and innovative tumor modeling to improve early cancer detection, mutation identification, and personalized treatment strategies. These advancements enhance diagnostic accuracy, reduce turnaround times, and address growing demand for localized, high-precision molecular testing. For example, in May 2024, OncoHelix-CoLab, a Canada-based precision oncology provider, launched a state-of-the-art laboratory at Burjeel Medical City in the UAE through a collaboration with Burjeel Holdings. The facility enables advanced molecular and immunology testing to be performed locally, strengthening regional diagnostic capabilities and supporting assays for multiple cancers, including prostate cancer through partnerships such as its collaboration on the ClarityDX Prostate test.

In June 2023, INEX Innovate Pte Ltd., a Singapore-based molecular diagnostic technology company, acquired Yourgene Health (Taiwan) Co., Ltd. for an undisclosed amount. Through this acquisition, INEX Innovate aims to strengthen its capabilities in fetal health, oncology research and development, and bioinformatics. Yourgene Health is a Taiwan-based genomics company and international molecular diagnostics group expanding its genetic testing portfolio to include oncology applications.

Major companies operating in the oncology molecular diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc., Guardant Health AMEA, Veracyte Inc., Adaptive Biotechnologies Corp., Foundation Medicine Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Genomic Health Inc.

North America was the largest region in the oncology molecular diagnostics market in 2025. Western Europe was the second largest region in the global oncology molecular diagnostics market report. The regions covered in the oncology molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The oncology molecular diagnostics market includes revenues earned by oncology molecular diagnostics tools and kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncology Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncology molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oncology molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Instruments; Reagents; Other Products
  • 2) By Technology: Polymerase Chain Reaction (PCR); In-Situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips And Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Other Technologies
  • 3) By End User: Hospitals; Diagnostic Centers; Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Platforms; Fluorescence In Situ Hybridization (FISH) Instruments
  • 2) By Reagents: DNA And RNA Extraction Kits; PCR Reagents And Kits; NGS Library Preparation Kits; Diagnostic Assay Reagents
  • 3) By Other Products: Software For Data Analysis And Interpretation; Quality Control And Calibration Products; Consumables; For Molecular Testing; Biomarkers For Oncology Testing
  • Companies Mentioned: F. Hoffmann-La Roche AG; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthcare AG; Becton Dickinson and Company; Agilent Technologies Inc.; HTG Molecular Diagnostics Inc.; Hologic Inc.; Illumina Inc.; bioMerieux SA; Beckman Coulter Inc.; Sysmex Corporation; Bio-Rad Laboratories Inc.; Qiagen N.V.; Exact Sciences Corp.; Bio-Techne Corporation; OPKO Health Inc.; Myriad Genetics Inc.; Guardant Health AMEA; Veracyte Inc.; Adaptive Biotechnologies Corp.; Foundation Medicine Inc.; Pacific Biosciences of California Inc.; NanoString Technologies Inc.; Genomic Health Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Oncology Molecular Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Oncology Molecular Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Oncology Molecular Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Oncology Molecular Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
  • 4.2. Major Trends
    • 4.2.1 Growth In Companion Diagnostics
    • 4.2.2 Rising Use Of Liquid Biopsy
    • 4.2.3 Expansion Of Biomarker-Based Testing
    • 4.2.4 Increasing Cancer Screening Programs
    • 4.2.5 Demand For Early And Accurate Cancer Detection

5. Oncology Molecular Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Centers
  • 5.3 Academic Institutes
  • 5.4 Research Laboratories
  • 5.5 Cancer Specialty Clinics

6. Oncology Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oncology Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Oncology Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Oncology Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Oncology Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Oncology Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oncology Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oncology Molecular Diagnostics Market Segmentation

  • 9.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments, Reagents, Other Products
  • 9.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), In-Situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips And Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies
  • 9.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Centers, Academic And Research Institutes, Other End Users
  • 9.4. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Platforms, Fluorescence In Situ Hybridization (FISH) Instruments
  • 9.5. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • DNA And RNA Extraction Kits, PCR Reagents And Kits, NGS Library Preparation Kits, Diagnostic Assay Reagents
  • 9.6. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software For Data Analysis And Interpretation, Quality Control And Calibration Products, Consumables, Biomarkers For Oncology Testing

10. Oncology Molecular Diagnostics Market Regional And Country Analysis

  • 10.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oncology Molecular Diagnostics Market

  • 11.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oncology Molecular Diagnostics Market

  • 12.1. China Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oncology Molecular Diagnostics Market

  • 13.1. India Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oncology Molecular Diagnostics Market

  • 14.1. Japan Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oncology Molecular Diagnostics Market

  • 15.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oncology Molecular Diagnostics Market

  • 16.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oncology Molecular Diagnostics Market

  • 17.1. South Korea Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oncology Molecular Diagnostics Market

  • 18.1. Taiwan Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oncology Molecular Diagnostics Market

  • 19.1. South East Asia Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oncology Molecular Diagnostics Market

  • 20.1. Western Europe Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oncology Molecular Diagnostics Market

  • 21.1. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oncology Molecular Diagnostics Market

  • 22.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oncology Molecular Diagnostics Market

  • 23.1. France Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oncology Molecular Diagnostics Market

  • 24.1. Italy Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oncology Molecular Diagnostics Market

  • 25.1. Spain Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oncology Molecular Diagnostics Market

  • 26.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oncology Molecular Diagnostics Market

  • 27.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oncology Molecular Diagnostics Market

  • 28.1. North America Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oncology Molecular Diagnostics Market

  • 29.1. USA Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oncology Molecular Diagnostics Market

  • 30.1. Canada Oncology Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oncology Molecular Diagnostics Market

  • 31.1. South America Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oncology Molecular Diagnostics Market

  • 32.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oncology Molecular Diagnostics Market

  • 33.1. Middle East Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oncology Molecular Diagnostics Market

  • 34.1. Africa Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Segmentation By Technology, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oncology Molecular Diagnostics Market Regulatory and Investment Landscape

36. Oncology Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Oncology Molecular Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Oncology Molecular Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Oncology Molecular Diagnostics Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Oncology Molecular Diagnostics Market Other Major And Innovative Companies

  • Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc.

38. Global Oncology Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market

40. Oncology Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Oncology Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Oncology Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Oncology Molecular Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer